May 2nd, 2014
A New Tool to Discuss Primary Prevention with a Statin with Patients: Life Expectancy Gain
Darrel P Francis, MD FRCP
Darrel Francis describes how you can use life expectancy gain as a way to communicate with patients the pros and cons of taking a statin.
NEJM Journal Watch — Recent Cardiology Articles- Atorvastatin vs. Rosuvastatin: Do Effectiveness and Safety Differ?
- Which Patients with Cardiogenic Shock Are at Risk for Early Death?
- Cardiac Magnetic Resonance Imaging for Risk Stratification in Nonischemic Cardiomyopathy
- Evidence Mounts for Triple Single-Pill Combination Therapy for Hypertension
- Atherosclerosis Burden and Progression on Imaging and Associated Mortality in Asymptomatic Patients